Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | H227 - Alzheimer's Network for Diagnostics and Therapy (ALZ-NET): Using Real World Evidence to Define the Future of Alzheimer's Treatment and Care (Research Hub)

Tuesday 04/25/23
01:00 PM - 01:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Heather M. Snyder, PhD
Aging and Dementia, Education, Research, and Methodology
The Alzheimer's Association, American College of Radiology, American Society of Neuroradiology, the Department of Biostatistics, Brown University School of Public Health and the Critical Path Institute, along with international clinical, research and imaging experts, have launched the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET).Networks of dementia clinics and imaging facilities are the foundation of ALZ-NET and will expand over time to include a variety of clinical practices. Patients about to start or already receiving treatment with a novel FDA-approved AD therapy will be eligible to enroll in ALZNET. ALZ-NET is structured to collect a data set that aligns with patient care, agnostic of therapy and care setting, including, baseline demographic, medical, neurologic, genetic and biomarker data. Join us to learn more about ALZ-NET.
0.00 CME credit
Patient Care & Procedural Skills, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:45 PM EST Speaker Alzheimer's Network for Diagnostics and Therapy (ALZ-NET) - Using Real World Evidence to Define the Future of Alzheimer's Treatment and Care
Heather M. Snyder, PhD, Michael S. Rafii, MD, PhD
Faculty Disclosures
Heather M. Snyder, PhD Dr. Snyder has received personal compensation for serving as an employee of Alzheimer's Association. An immediate family member of Dr. Snyder has received personal compensation for serving as an employee of Abbott . An immediate family member of Dr. Snyder has stock in Medtronic. The institution of Dr. Snyder has received research support from National Institute on Aging.
Michael S. Rafii, MD, PhD Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.